科達利(002850.SZ):通過諧波減速器等產品業務,拓展人形機器人關節部件領域
格隆匯12月10日丨科達利(002850.SZ)在投資者互動平台表示,公司立足於全球市場,着眼於人形機器人在工業領域未來的發展潛力,進軍機器人賽道,通過諧波減速器等產品業務,拓展人形機器人關節部件領域。作為國內動力電池精密結構件領域的領軍企業,公司多年來始終聚焦主業,積累了豐富的技術經驗和優秀的精密結構件製造能力。通過與合作方的合作促進技術整合和創新,提升產品附加值。同時依託公司現有廠房,積極開展產線建設,通過前期的深入調研及大量研發製造投入,公司將構建新的競爭優勢,為未來產業佈局奠定堅實基礎,有望拓展公司第二發展曲線,進一步擴大公司整體的經營效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.